Lantern Pharma Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Lantern Pharma Inc. (LTRN) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $38.70 thousand as of 2021-09-30, per its 10-Q filed 2021-11-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2021-11-01
- 2021-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $38.70K.
- 2021-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $77.40K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2021-09-30 | $38.70K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $77.40K 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |